OA18.04 Tumor-Derived Complement C3 as a Therapeutic Target in STK11 Mutant Non-Small Cell Lung Cancer

Autor: Yau, E., Suzuki, S., Kandar, B., Ting, C., Giridharan, T., Stokolosa, A., Khan, A.N., Segal, B.
Zdroj: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S86-S86
Databáze: ScienceDirect